Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Impact of system delay on infarct size, myocardial salvage index, and left ventricular function in patients with ST-segment elevation myocardial infarction.

Lønborg J, Schoos MM, Kelbæk H, Holmvang L, Steinmetz J, Vejlstrup N, Jørgensen E, Helqvist S, Saunamäki K, Bøtker HE, Kim WY, Terkelsen CJ, Clemmensen P, Engstrøm T.

Am Heart J. 2012 Oct;164(4):538-46. doi: 10.1016/j.ahj.2012.07.021.

PMID:
23067912
2.

Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.

Woo JS, Kim W, Ha SJ, Kim JB, Kim SJ, Kim WS, Seon HJ, Kim KS.

Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2252-60. doi: 10.1161/ATVBAHA.113.301586. Epub 2013 Jul 18.

3.

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.

Lønborg J, Vejlstrup N, Kelbæk H, Bøtker HE, Kim WY, Mathiasen AB, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Thuesen L, Krusell LR, Jensen JS, Køber L, Treiman M, Holst JJ, Engstrøm T.

Eur Heart J. 2012 Jun;33(12):1491-9. doi: 10.1093/eurheartj/ehr309. Epub 2011 Sep 14.

PMID:
21920963
4.

Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.

Francone M, Bucciarelli-Ducci C, Carbone I, Canali E, Scardala R, Calabrese FA, Sardella G, Mancone M, Catalano C, Fedele F, Passariello R, Bogaert J, Agati L.

J Am Coll Cardiol. 2009 Dec 1;54(23):2145-53. doi: 10.1016/j.jacc.2009.08.024.

5.

Relationship between treatment delay and final infarct size in STEMI patients treated with abciximab and primary PCI.

Tödt T, Maret E, Alfredsson J, Janzon M, Engvall J, Swahn E.

BMC Cardiovasc Disord. 2012 Feb 23;12:9. doi: 10.1186/1471-2261-12-9.

6.

Relation of left ventricular infarct transmurality and infarct size after primary percutaneous coronary angioplasty to time from symptom onset to balloon inflation.

Hahn JY, Song YB, Gwon HC, Choe YH, Kim JH, Sung J, Choi SH, Choi JH, Kim DK, Hong KP, Park JE, Lee SH.

Am J Cardiol. 2008 Nov 1;102(9):1163-9. doi: 10.1016/j.amjcard.2008.06.042. Epub 2008 Aug 19.

PMID:
18940285
7.

Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study.

Haeck JD, Kuijt WJ, Koch KT, Bilodeau L, Henriques JP, Rohling WJ, Baan J Jr, Vis MM, Nijveldt R, van Geloven N, Groenink M, Piek JJ, Tijssen JG, Krucoff MW, De Winter RJ.

Heart. 2010 Feb;96(3):190-5. doi: 10.1136/hrt.2009.180448. Epub 2009 Oct 26.

PMID:
19858136
8.

Influence of ST-segment recovery on infarct size and ejection fraction in patients with ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention.

Hallén J, Sejersten M, Johanson P, Atar D, Clemmensen PM.

Am J Cardiol. 2010 May 1;105(9):1223-8. doi: 10.1016/j.amjcard.2009.12.034. Epub 2010 Mar 11.

PMID:
20403470
9.

Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction.

Ganame J, Messalli G, Dymarkowski S, Rademakers FE, Desmet W, Van de Werf F, Bogaert J.

Eur Heart J. 2009 Jun;30(12):1440-9. doi: 10.1093/eurheartj/ehp093. Epub 2009 Apr 3.

PMID:
19346229
10.
11.

Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".

Bruder O, Breuckmann F, Jensen C, Jochims M, Naber CK, Barkhausen J, Erbel R, Sabin GV; Herzinfarktverbund Essen.

Herz. 2008 Mar;33(2):136-42. doi: 10.1007/s00059-008-3102-8.

PMID:
18344033
12.

Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia.

Lønborg J, Kelbæk H, Vejlstrup N, Bøtker HE, Kim WY, Holmvang L, Jørgensen E, Helqvist S, Saunamäki K, Terkelsen CJ, Schoos MM, Køber L, Clemmensen P, Treiman M, Engstrøm T.

Circ Cardiovasc Interv. 2012 Apr;5(2):288-95. doi: 10.1161/CIRCINTERVENTIONS.112.968388. Epub 2012 Apr 10.

13.

Relation of ST-segment elevation before and after percutaneous transluminal coronary angioplasty to left ventricular area at risk, myocardial infarct size, and systolic function.

Rodríguez-Palomares JF, Figueras-Bellot J, Descalzo M, Moral S, Otaegui I, Pineda V, Del Blanco BG, González-Alujas MT, Evangelista Masip A, García-Dorado D.

Am J Cardiol. 2014 Feb 15;113(4):593-600. doi: 10.1016/j.amjcard.2013.11.007. Epub 2013 Nov 23. Erratum in: Am J Cardiol. 2014 Apr 15;113(8):1448. Moral, Sergi [corrected to Moral, Sergio].

PMID:
24484860
14.

Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction.

Mills JS, Mahaffey KW, Lokhnygina Y, Nicolau JC, Ruzyllo W, Adams PX, Todaro TG, Armstrong PW, Granger CB; CARDINAL investigators.

Coron Artery Dis. 2012 Mar;23(2):118-25. doi: 10.1097/MCA.0b013e32834e4f8f.

PMID:
22217457
15.

Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial).

Brodie BR, Webb J, Cox DA, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Dulas D, Rutherford B, Antoniucci D, Stuckey T, Krucoff M, Gibbons R, Lansky A, Na Y, Mehran R, Stone GW; EMERALD Investigators.

Am J Cardiol. 2007 Jun 15;99(12):1680-6. Epub 2007 May 7.

PMID:
17560875
16.

Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.

Ndrepepa G, Tiroch K, Keta D, Fusaro M, Seyfarth M, Pache J, Mehilli J, Schömig A, Kastrati A.

Circ Cardiovasc Interv. 2010 Feb 1;3(1):27-33. doi: 10.1161/CIRCINTERVENTIONS.109.896225. Epub 2010 Jan 26.

17.

[Minimum salvaged myocardium after rescue percutaneous coronary intervention: quantification by cardiac magnetic resonance].

Ruiz-Nodar JM, Feliu E, Sánchez-Quiñones J, Valencia-Martín J, García M, Pineda J, Martín P, Mainar V, Bordes P, Heras S, Quintanilla MA, Sogorb F.

Rev Esp Cardiol. 2011 Nov;64(11):965-71. doi: 10.1016/j.recesp.2011.04.014. Epub 2011 Jul 23. Spanish.

18.

Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.

Ezekowitz JA, Armstrong PW, Granger CB, Theroux P, Stebbins A, Kim RJ, Patel MR.

Am Heart J. 2010 Aug;160(2):272-8. doi: 10.1016/j.ahj.2010.05.035.

PMID:
20691832
19.

Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct.

Pride YB, Giuseffi JL, Mohanavelu S, Harrigan CJ, Manning WJ, Gibson CM, Appelbaum E.

Am J Cardiol. 2010 Sep 1;106(5):635-40. doi: 10.1016/j.amjcard.2010.04.012.

PMID:
20723637
20.

ST-segment resolution assessed immediately after primary percutaneous coronary intervention correlates with infarct size and left ventricular function in cardiac magnetic resonance at 1-year follow-up.

Rakowski T, Dziewierz A, Siudak Z, Mielecki W, Brzozowska-Czarnek A, Legutko J, Rzeszutko L, Urbanik A, Dubiel JS, Dudek D.

J Electrocardiol. 2009 Mar-Apr;42(2):152-6. doi: 10.1016/j.jelectrocard.2008.12.002. Epub 2009 Jan 22.

PMID:
19167012

Supplemental Content

Support Center